Generic Arynta Availability
Last updated on Jul 9, 2025.
Arynta is a brand name of lisdexamfetamine, approved by the FDA in the following formulation(s):
ARYNTA (lisdexamfetamine dimesylate - solution;oral)
-
Manufacturer: AZURITY
Approval date: June 16, 2025
Strength(s): 10MG/ML [RLD]
Is there a generic version of Arynta available?
No. There is currently no therapeutically equivalent version of Arynta available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Arynta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
Related patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Oral solutions comprising lisdexamfetamine salts
Patent 11,576,878
Issued: February 14, 2023
Inventor(s): Liolios; Georgios et al.
Assignee(s): LABOMED PHARMACEUTICAL COMPANY S.A. (Koropi, GR)Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
Patent expiration dates:
- August 30, 2040✓
- August 30, 2040
More about Arynta (lisdexamfetamine)
- Check interactions
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Related/similar drugs
Vyvanse
Vyvanse is a prescription stimulant used to treat ADHD in children and adults, and binge eating ...
Adderall
Adderall (amphetamine and dextroamphetamine) is used to treat narcolepsy and ADHD. Includes side ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Adipex-P
Adipex-P (phentermine) is an appetite suppressant used togther with diet and exercise to treat ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.